Stock Chart

PSNL

$15.71 -0.95%
Score: 49.9 HOLD
LEAPs: SELL $15
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $15
Premium: $2.50
Expiry: Dec 17, 2027
Target: $15
Score: -93

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.20x (vs SPY: 1.6x | vs QQQ: 1.5x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 13, 2026
Descending Triangle Bearish scenario quality 82/100
Measured-move target $15.28 (-2.7%) · apex ~15 bars ahead
Break direction historically ~even (52% up, n=87) — scenario shown, not a forecast
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About PSNL - Personalis, Inc. Common Stock

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Key Statistics

Market Cap $2B

More PSNL Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This PSNL stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PSNL's price movements with trendlines, gamma walls, and key support/resistance levels.